Connect
MJA
MJA

Pharmaceutical Preparations

Editorials

Opioid prescribing in Australia: too much and not enough

Adrian J Dunlop, Buddhima Lokuge and Nicholas Lintzeris

Med J Aust 2021; 215 (3): 117-118 Free

Research

Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners

Heidi J Welberry, Louisa R Jorm, Andrea L Schaffer, Sebastiano Barbieri, Benjumin Hsu, Mark F Harris, John Hall and Henry Brodaty

Med J Aust 2021; 215 (3): 130-136 Free

Research letter

Opioid medication prescribing in Queensland, 1997‒2018: a population study

Adeleke D Adewumi, Joemer C. Maravilla, Rosa Alati, Samantha A Hollingworth, Xuelei Hu, Bill Loveday and Jason Connor

Med J Aust 2021; 215 (3): 137-138 Free

Perspectives

When will opioid agonist therapy become a normal part of comprehensive health care?

Pallavi Prathivadi and Elizabeth A Sturgiss

Med J Aust 2021; 214 (11): 504-505.e1

Letters

Buprenorphine: extended‐release formulations “a game changer”!

Katerina Lagios

Med J Aust 2021; 214 (11): 534-534.e1

Editorials

Lack of efficacy of cannabidiol for relieving back pain: time to re‐set expectations?

Chris Hayes and Jennifer H Martin

Med J Aust 2021; 214 (8): 360-361

Research letters

Increased dispensing of prescription medications in Australia early in the COVID‐19 pandemic

Mustafa Mian, Subhashaan Sreedharan and Sarah Giles

Med J Aust 2021; 214 (9): 428-429 Free

Research letters

Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services

Hilarie Tardif, Christopher Hayes and Samuel F Allingham

Med J Aust 2021; 214 (9): 430-432 Free

Perspectives

Should we be routinely co‐prescribing naloxone for patients on long term opioids?

Pallavi Prathivadi and Suzanne Nielsen

Med J Aust 2021; 214 (9): 403-404.e1

Research

The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

Bronwyn Bebee, David M Taylor, Elyssia Bourke, Kimberley Pollack, Lian Foster, Michael Ching and Anselm Wong

Med J Aust 2021; 214 (8): 370-375 Free

Letters

Confusion about doxylamine safety in pregnancy

Debra S Kennedy and Ronald P Batagol

Med J Aust 2021; 214 (6): 286-286.e1

Systematic reviews

The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews

Christina Abdel Shaheed, Giovanni E Ferreira, Alissa Dmitritchenko, Andrew J McLachlan, Richard O Day, Bruno Saragiotto, Christine Lin, Vicki Langendyk, Fiona Stanaway, Jane Latimer, Steven Kamper, Hanan McLachlan, Harbeer Ahedi and Christopher G Maher

Med J Aust 2021; 214 (7): 324-331 Free

Perspectives

Screening for hydroxychloroquine retinopathy in Australia

Marisse T Sonido, Kristopher Rallah-Baker and Monisha Gupta

Med J Aust 2021; 214 (7): 301-302.e1

Editorials

Biosimilars: is interchangeability the proof of the pudding?

Gregory T Moore and Charlotte Keung

Med J Aust 2021; 214 (3): 124-125

Research letters

Residential medication management reviews in Australian residential aged care facilities

Janet K Sluggett, J Simon Bell, Catherine Lang, Megan Corlis, Craig Whitehead, Steven L Wesselingh and Maria C Inacio

Med J Aust 2021; 214 (9): 432-433 Free

Perspectives

Putting the “good” into Good Clinical Practice

Tanya Symons, Steve Webb and John R Zalcberg

Med J Aust 2021; 214 (2): 62-65.e1

Letters

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Emily J Meyer, Venkatesan Thiruvenkatarajan and David Jesudason

Med J Aust 2021; 214 (2): 93-93.e1

Letters

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong and Leon A Bach

Med J Aust 2021; 214 (2): 94-94.e1

Medical history

Meningitis and the military: the remarkable story of the first use of penicillin in Australia (1943)

Ameneh Khatami, Philip N Britton, Glendon Farrow, Megan Phelps and Alyson Kakakios

Med J Aust 2020; 213 (11): 508-510.e1

Research

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

Craig Haifer, Ashish Srinivasan, Yoon‐Kyo An, Sherman Picardo, Daniel Langenberg, Shankar Menon, Jakob Begun, Simon Ghaly and Lena Thin

Med J Aust 2021; 214 (3): 128-133 Free

Editorials

Opioid stewardship can reduce inappropriate prescribing of opioids at hospital discharge

Stephan A Schug

Med J Aust 2020; 213 (9): 409-410

Research

Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial

Ria E Hopkins, Thuy Bui, Alex H Konstantatos, Carolyn Arnold, Dianna J Magliano, Danny Liew and Michael J Dooley

Med J Aust 2020; 213 (9): 417-423 Free

Editorials

Red‐flagging the prescribing of oral corticosteroids for people with asthma

Christine F McDonald and Christopher J Worsnop

Med J Aust 2020; 213 (7): 313-314

Letters

Unintended consequences of using real time prescription monitoring systems

Sarah Haines, Michael Savic, Louisa Picco, Suzanne Nielsen and Adrian Carter

Med J Aust 2020; 213 (3): 142-142.e1

Narrative review

Clinical trials for the prevention and treatment of COVID‐19: current state of play

Joshua S Davis, David Ferreira, Justin T Denholm and Steven YC Tong

Med J Aust 2020; 213 (2): 86-93 Free